BCM
TEVA icon

Brown Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Brown Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-498,348
Closed -$7.81M – 123
2019
Q1 		$7.81M Hold
498,348
– – 0.08% 47
2018
Q4 		$7.68M Sell
498,348
-1,985
-0.4% -$40.7K 0.09% 48
2018
Q3 		$10.8M Buy
500,333
+4,912
+1% +$114K 0.1% 45
2018
Q2 		$12M Buy
495,421
+151,895
+44% +$3.1M 0.12% 43
2018
Q1 		$5.87M Buy
343,526
+92,571
+37% +$1.81M 0.07% 51
2017
Q4 		$4.76M Sell
250,955
-1,349
-0.5% -$20.3K 0.06% 55
2017
Q3 		$4.44M Hold
252,304
– – 0.05% 52
2017
Q2 		$8.38M Sell
252,304
-31,626
-11% -$979K 0.1% 50
2017
Q1 		$9.11M Sell
283,930
-5,435
-2% -$185K 0.12% 48
2016
Q4 		$10.5M Sell
289,365
-4,580
-2% -$183K 0.15% 46
2016
Q3 		$13.5M Buy
293,945
+42,608
+17% +$2.22M 0.2% 45
2016
Q2 		$12.6M Buy
251,337
+1,548
+0.6% +$82.4K 0.2% 46
2016
Q1 		$13.4M Buy
249,789
+1,928
+0.8% +$113K 0.22% 48
2015
Q4 		$16.3M Buy
247,861
+3,065
+1% +$189K 0.25% 46
2015
Q3 		$13.8M Buy
244,796
+17,880
+8% +$1.16M 0.24% 51
2015
Q2 		$13.4M Buy
226,916
+2,911
+1% +$180K 0.22% 55
2015
Q1 		$14M Hold
224,005
– – 0.23% 52
2014
Q4 		$12.9M Sell
224,005
-48,073
-18% -$2.68M 0.22% 53
2014
Q3 		$14.6M Buy
272,078
+2,610
+1% +$138K 0.26% 54
2014
Q2 		$14.1M Sell
269,468
-6,514
-2% -$333K 0.24% 56
2014
Q1 		$14.6M Sell
275,982
-2,084
-0.7% -$96.3K 0.24% 55
2013
Q4 		$11.1M Sell
278,066
-21,518
-7% -$847K 0.18% 57
2013
Q3 		$11.3M Sell
299,584
-8,001
-3% -$312K 0.2% 60
2013
Q2 		$12.1M Buy
+307,585
New +$12M 0.26% 56

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Brown Capital Management's TEVA Position: Q2 2019 in Review

Brown Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2019, closing a stake of 498,348 shares — an estimated $7.81M sold.

Brown Capital Management first reported a position in TEVA in Q2 2013 and held it in 24 quarters. The position peaked at $16.3M in Q4 2015. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

  • Brown Capital Management reported no remaining Teva Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Brown Capital Management sold 498,348 Teva Pharmaceuticals shares in Q2 2019, an estimated $7.81M.
  • Brown Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 24 quarters.
  • Brown Capital Management's Teva Pharmaceuticals position peaked at $16.3M in Q4 2015.
  • 452 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2019.

Based on Brown Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.